| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLNO | Common Stock | Sale | -$54.7K | -1.33K | -5.19% | $41.12 | 24.3K | Apr 1, 2024 | Direct | F1, F2, F3 |
| transaction | SLNO | Common Stock | Sale | -$37K | -888 | -3.65% | $41.67 | 23.4K | Apr 1, 2024 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
| F2 | This transaction was executed in multiple trades at prices ranging from $40.42 to $41.415. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| F4 | This transaction was executed in multiple trades at prices ranging from $41.42 to $42.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Officer title: Senior Vice President, Clinical Operations